Model | Overall | Males | Females | 18–44 years | 45–64 years | 65+ years |
|---|
1 | 167,249 | 73,418 | 93,565 | 42,925 | 71,311 | 26,719 |
2 | 166,994 | 73,405 | 93,493 | 42,921 | 70,983 | 26,554 |
3 | 166,506 | 73,181 | 93,351 | 42,421 | 71,033 | 26,622 |
4 |
165,719
|
72,706
|
92,688
|
42,220
|
70,483
|
26,525
|
- PSSA Probabilistic-based sensitivity-specificity adjusted method, PSSA, model 1 covariates are sex, age group, region, income quintile, Charlson comorbidity score, chronic obstructive pulmonary disease (A, E), diabetes (A, E), depression (A, E), dementia (A, E), obesity (A, E), cerebrovascular disease (A), congestive heart failure (A), coronary heart disease (A), renal disease (A), substance abuse (A); PSSA, model 2 covariates sex, age group, region, income quintile, chronic obstructive pulmonary disease (E), diabetes (E), depression (E), dementia (E), obesity (E), cerebrovascular disease (A), congestive heart failure (A), coronary heart disease (A), renal disease (A), substance abuse (A); PSSA, model 3 covariates are sex, age group, region, income quintile, chronic obstructive pulmonary disease (E), diabetes (E), depression (E), dementia (E), obesity (E), coronary heart disease (A), renal disease (A), substance abuse (A); PSSA, model 4 covariates are sex, age group, chronic obstructive pulmonary disease (E), diabetes (E), obesity (E), coronary heart disease (A), congestive heart failure (A), substance abuse (A); A and E denote disease-specific markers that were identified from AHRs and EMRs, respectively; Values in bold-face font represent the best-fitting model
